A carregar...
Tumor-specific Immunotherapy Targeting the EGFRvIII Mutation in Patients with Malignant Glioma
Conventional therapies for malignant gliomas (MGs) fail to target tumor cells exclusively, such that their efficacy is ultimately limited by non-specific toxicity. Immunologic targeting of tumor-specific gene mutations, however, may allow more precise eradication of neoplastic cells. The epidermal g...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2633865/ https://ncbi.nlm.nih.gov/pubmed/18539480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2008.04.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|